{"transactions":[{"id":1100704,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"ten_percent_owner":true}},{"id":78076,"kind":"organization","name":"Fosun Pharma USA Inc.","position":2,"cik":"0002071437","reported_name":"Fosun Pharma USA Inc.","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-06-27T20:27:23.000Z","date":"2025-06-27","kind":"sale","planned":false,"acquired":false,"shares":2854607,"price":11.46,"value":32713796.22,"ownership":{"direct":false,"nature":"by Fosun Pharma USA Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to that certain Underwriting Agreement. dated June 25, 2025, among Fosun Pharma USA Inc., the Issuer, and the underwriter party thereto."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Pharma USA Inc. is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-25-023976","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/275053/000114036125023976/form4.xml","form_type":"4"}},{"id":1385471,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-17T10:00:14.000Z","date":"2024-10-15","kind":"sale","planned":false,"acquired":false,"shares":2300,"price":13.02,"value":29946.0,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person."}],"balance_after":64167,"source":{"system":"sec-edgar","filing":"0001104659-24-109317","document":"tm2426270-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/275053/000110465924109317/tm2426270-1_4seq1.xml","form_type":"4"}},{"id":1387289,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-15T12:48:41.000Z","date":"2024-10-14","kind":"sale","planned":false,"acquired":false,"shares":1300,"price":13.12,"value":17056.0,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person."}],"balance_after":66467,"source":{"system":"sec-edgar","filing":"0001104659-24-108390","document":"tm2426189-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/275053/000110465924108390/tm2426189-1_4seq1.xml","form_type":"4"}},{"id":1387288,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-15T12:48:41.000Z","date":"2024-10-11","kind":"sale","planned":false,"acquired":false,"shares":1580,"price":13.37,"value":21124.6,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person."}],"balance_after":67767,"source":{"system":"sec-edgar","filing":"0001104659-24-108390","document":"tm2426189-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/275053/000110465924108390/tm2426189-1_4seq1.xml","form_type":"4"}},{"id":1387287,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-15T12:48:41.000Z","date":"2024-10-10","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":13.39,"value":40170.0,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person."}],"balance_after":69347,"source":{"system":"sec-edgar","filing":"0001104659-24-108390","document":"tm2426189-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/275053/000110465924108390/tm2426189-1_4seq1.xml","form_type":"4"}},{"id":1387286,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-15T12:48:41.000Z","date":"2024-10-09","kind":"sale","planned":false,"acquired":false,"shares":1816,"price":13.36,"value":24261.76,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person."}],"balance_after":72347,"source":{"system":"sec-edgar","filing":"0001104659-24-108390","document":"tm2426189-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/275053/000110465924108390/tm2426189-1_4seq1.xml","form_type":"4"}},{"id":1387285,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-15T12:48:41.000Z","date":"2024-10-08","kind":"sale","planned":false,"acquired":false,"shares":1800,"price":13.13,"value":23634.0,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person."}],"balance_after":74163,"source":{"system":"sec-edgar","filing":"0001104659-24-108390","document":"tm2426189-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/275053/000110465924108390/tm2426189-1_4seq1.xml","form_type":"4"}},{"id":1387284,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-15T12:48:41.000Z","date":"2024-10-01","kind":"sale","planned":false,"acquired":false,"shares":1399,"price":13.54,"value":18942.46,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person."}],"balance_after":75963,"source":{"system":"sec-edgar","filing":"0001104659-24-108390","document":"tm2426189-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/275053/000110465924108390/tm2426189-1_4seq1.xml","form_type":"4"}},{"id":1387283,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-15T12:48:41.000Z","date":"2024-09-06","kind":"other","planned":false,"acquired":true,"shares":2968,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent shares that were issued to Fosun Industrial Co., Limited upon the delivery of certain vested restricted stock units that were initially granted to a former director of the Issuer (the \"Former Director\"), as agreed between the Former Director and the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person."}],"balance_after":77362,"source":{"system":"sec-edgar","filing":"0001104659-24-108390","document":"tm2426189-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/275053/000110465924108390/tm2426189-1_4seq1.xml","form_type":"4"}},{"id":2428330,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-24T14:56:26.000Z","date":"2022-01-21","kind":"other","acquired":true,"shares":25000,"price":8.72,"value":218000.0,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of the Former Director upon the exercise of certain stock options (the \"Options\") that were initially granted to the Former Director, as agreed between the Former Director and the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the exercise price paid by Fosun Industrial Co., Limited for the shares underlying the Options upon the exercise of the Options."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person."}],"balance_after":74394,"source":{"system":"sec-edgar","filing":"0001104659-22-006711","document":"tm224261-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/275053/000110465922006711/tm224261-1_4seq1.xml","form_type":"4"}},{"id":2428329,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-24T14:56:26.000Z","date":"2022-01-07","kind":"other","acquired":true,"shares":9558,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of the Former Director upon the delivery of certain vested restricted stock units that were initially granted to the Former Director, as agreed between the Former Director and the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person."}],"balance_after":49394,"source":{"system":"sec-edgar","filing":"0001104659-22-006711","document":"tm224261-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/275053/000110465922006711/tm224261-1_4seq1.xml","form_type":"4"}},{"id":2428328,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-24T14:56:26.000Z","date":"2021-04-12","kind":"other","acquired":true,"shares":711,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent incremental shares granted by the Issuer as an adjustment to the vested option award of a former director of the Issuer (the \"Former Director\"). These shares initially reported on a Form 4 filed by the Former Director, but were actually issued to Fosun Industrial Co., Limited. Due to this oversight, a Form 4 was not previously filed by the Reporting Person regarding this issuance."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person."}],"balance_after":39836,"source":{"system":"sec-edgar","filing":"0001104659-22-006711","document":"tm224261-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/275053/000110465922006711/tm224261-1_4seq1.xml","form_type":"4"}},{"id":3343147,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, no par value per share","published_at":"2019-12-13T11:10:51.000Z","date":"2019-12-11","kind":"other","acquired":true,"shares":25000,"price":7.8,"value":195000.0,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of a former director of the Issuer upon the exercise of certain stock options (the \"Options\") that were initially granted to the former director, as agreed between the former director and the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the exercise price paid by Fosun Industrial Co., Limited on behalf of the former director of the Issuer for the shares underlying the Options upon the exercise of the Options."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Industrial Co., Limited is a wholly owned subsidiary of the Reporting Person."}],"balance_after":39125,"source":{"system":"sec-edgar","filing":"0001104659-19-072359","document":"tm1925169-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/275053/000110465919072359/tm1925169-1_4.xml","form_type":"4"}},{"id":3343146,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, no par value per share","published_at":"2019-12-13T11:10:51.000Z","date":"2019-12-11","kind":"other","acquired":true,"shares":14125,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of a former director of the Issuer upon the vesting of certain restricted stock units that were initially granted to the former director, as agreed between the former director and the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Industrial Co., Limited is a wholly owned subsidiary of the Reporting Person."}],"balance_after":14125,"source":{"system":"sec-edgar","filing":"0001104659-19-072359","document":"tm1925169-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/275053/000110465919072359/tm1925169-1_4.xml","form_type":"4"}},{"id":3741609,"issuer":{"id":116797,"kind":"organization","name":"CONTRAFECT Corp","symbol":"CFRX"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-06T16:51:27.000Z","date":"2018-12-04","kind":"sale","acquired":false,"shares":600000,"price":2.04,"value":1224000.0,"ownership":{"direct":false,"nature":"by Fosun Industrial Co., Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Fosun Industrial Co., Limited is a wholly owned subsidiary of the Reporting Person."}],"balance_after":7900000,"source":{"system":"sec-edgar","filing":"0001144204-18-063392","document":"tv508579_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478069/000114420418063392/tv508579_4.xml","form_type":"4"}}]}